Gilead Sciences, Inc.(GILD)

Description: Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes human therapeutics for the treatment of life threatening diseases in North America, Europe, and Asia. Its products include Stribild, Complera/Eviplera, Atripla, Truvada, Viread, and Emtriva for the treatment of human immunodeficiency virus (HIV) infection in adults; and Viread and Hepsera products for the treatment of liver disease. The company also offers Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa, a tablet used for the treatment of chronic angina; Lexiscan/Rapiscan injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging; Cayston, an inhaled antibiotic for the treatment of respiratory systems in cystic fibrosis patients; and Tamiflu, an oral antiviral capsule for the treatment and prevention of influenza A and B. In addition, it provides other products, such as AmBisome, an antifungal agent to treat serious invasive fungal infections; Vistide, an antiviral injection for the treatment of cytomegalovirus retinitis in patients with AIDS; and Macugen, an anti-angiogenic oligonucleotide to treat neovascular macular degeneration. Further, it has product candidates in various stages for the treatment of cardiovascular diseases, respiratory diseases, and oncology diseases/inflammation. The company markets its products through its commercial teams and/or in conjunction with third-party distributors and corporate partners. Gilead Sciences, Inc. has collaborations with BMS, GSK, Janssen, and Japan Tobacco to develop and commercialize various products. The company was founded in 1987 and is headquartered in Foster City, California.

---

Keywords: Medicine Biopharmaceutical S&P 500 Disease Antibiotics Infection Nasdaq 100 Inflammation Hypertension Cardiovascular Disease Influenza HIV Respiratory Diseases Organic Chemistry Liver Disease Macular Degeneration Vascular Disease Hepatotoxins Pulmonary Arterial Hypertension Cystic Fibrosis Coronavirus Angina Immunodeficiency Prodrugs Gilead Sciences Oligonucleotide Perfusion Fungal Infection Fungal Infections Retinitis Tenofovir Disoproxil Oncology Diseases Treatment Of Cardiovascular Diseases Ranexa Atripla Chronic Angina Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Letairis Respiratory Systems Stribild Treatment Of Cardiovascular Disease Truvada Viread Cytomegalovirus Retinitis Emtricitabine Fixed Dose Combination Myocardial Perfusion Imaging Treatment Of Life Threatening Diseases

---

Home Page: www.gilead.com

GILD Technical Analysis

333 Lakeside Drive
Foster City, CA 94404
United States
Phone: 650 574 3000

---

Officers

Exchange: NASDAQ

Country: US : United States of America

Currency: US Dollar ($)